C7731

咖啡因

meets USP testing specifications, anhydrous

• 别名: 1,3,7-三甲基黄嘌呤
• 经验公式（希尔记法）: C₈H₁₀N₄O₂
• CAS号: 58-08-2
• 分子量: 194.19
• Beilstein: 17705
• EC號碼: 200-362-1
• MDL號碼: MFCD00005758
• 分類程式碼代碼: 12352210
• PubChem物質ID: 24892984
• NACRES: NA.21

属性

• 等級: anhydrous
• 品質等級: 200
• agency: USP/NF; meets USP testing specifications
• 形狀: crystalline; powder
• mp: 234-236.5 °C (lit.)
• 溶解度: H₂O: soluble 18.7 g/L at 16 °C
• SMILES 字串: CN1C(=O)N(C)c2ncn(C)c2C1=O
• InChI: 1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3
• InChI 密鑰: RYYVLZVUVIJVGH-UHFFFAOYSA-N
• 基因資訊: human ... ADORA1(134) , ADORA2A(135) , ADORA2B(136) , ADORA3(140) , PDE4B(5142) ; mouse ... Adora2b(11541) ; rat ... Adora1(29290) , Adora2a(25369)

说明

一般說明

Caffeine is a commonly consumed pharmacologically active substance. It is a member of the class of methylxanthines. It is a natural alkaloid found in coffee, cocoa and other plants. Caffeine might be linked to osteoporosis, cardiovascular risk, arrhythmia and gastrointestinal disturbances. Caffeine is used to treat orthostatic hypotension, bronchopulmonary dysplasia and apnea of prematurity (AOP).

應用

Caffeine has been used:

• to functionally disable Ca²⁺ removal via sarco/endoplasmic reticulum Ca²⁺ ATPase (SERCA)
• to determine its effects in overcoming excitation-contraction-coupling failure
• to compare its role as a stimulant with guarana

安全信息

• 象形圖: GHS07
• 訊號詞: Warning
• 危險聲明: H302
• 防範說明: P301 + P312 + P330
• 危險分類: Acute Tox. 4 Oral
• 儲存類別代碼: 13 - Non Combustible Solids
• 水污染物質分類（WGK）: WGK 1
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable
• 個人防護裝備: dust mask type N95 (US), Eyeshields, Faceshields, Gloves